Genus said on Monday it will acquire a major stake in In Vitro Brasil (IVB), a bovine in-vitro fertilisation technology provider.Its bovine genetics business ABS will buy 51% of the share capital of IVB for £4.6m. The transaction is expected to be completed during the first quarter of 2015 and Genus
Read moreTSB Banking: Shore Capital reiterates buy with a target price for 325p. Vernalis: Canaccord Genuity ups target to 66p from 56p and reiterates buy. Aggreko: Panmure Gordon and Investec reiterate hold. Gemfields: Numis initiates coverage with a buy recommendation and 70p target price. Ithaca Energy
Read moreShares in technology products distributor Premier Farnell took a hit after the group warned that its full-year operating margin would be "slightly" below prior year levels. The group experienced softer market conditions in Asia and Europe, which dragged the gross margin 0.5 percentage points lower.
Read moreGenus reported a performance in-line with expectations for the period since 1 July, with an increase seen across volumes, revenues and adjusted profit before tax. However, growth at the animal genetics company in actual currency terms came in at a lower rate than in constant currency. The group sai
Read more